TAGLines index

Volume 12, Issue 1, January 2005
PHS Panel Embraces Treatment Interruption, Squandering Public Goodwill and Scarce Research Funds To Boot, Timeline for the Initiation of the RV144 Prime-Boost Trial, Late 2004 Changes to Federal (DHHS) Treatment Guidelines, Tangle of Interests and Disclosure Omissions Cracks Authors' Case For Early, Aggressive Treatment, Brown University Clinician Leads the Way In Providing Competent Care To Coinfected Injectors, Letters to the Editor (added 1/19/05)
Volume 11, Issue 11, December 2004
Questioning the firewall, Does Gilead's Famed 903 Study Really Show You What They Tell You It Shows? Cell Therapy aka Therapeutic 'Vaccine' Surprise Announcement for World AIDS Day, Why the Tap 'n' Drainers Have Always Been Wrong; Plus, A New Theory About MDR HIV, Mixed Results (and Lots of Diarrhea) for the Tipranavir Studies; Plus Salvage Study Designs for JNJ/Tibotec's PI and Non-nuke, Who provides you with up-to-date treatment information? (added 12/3/04)
Volume 11, Issue 10, October 2004
The Panel Speaks: PHS Guidelines ban hydroxyurea, Vaccine Scientists Struggle To Come To Grips With the Field's Berlin, Gilead 2-in-1 Opens Door To Impending One Pill Triple Combo (updated 10/21/04)
Volume 11, Issue 9, September 2004
The Truth About the Drug Companies, The Irony of Bangkok, The Agony of Bangkok, Prescription for Profits (updated 9/14/04)
Volume 11, Issue 8, August 2004 en español
Statin Strength: Relative potency of the HMG-CoA reductase inhibitors (aka statins), TDM, Stat! More Mixes Nixed By Concentration Preoccupations, French Researchers Question Benefit of Lifelong Antiretroviral Treatment, Treatment Advocates Strategize At TAG's 2nd Annual International TB/HIV Workshop (added 8/8/04)
Volume 11, Issue 7, July 2004 en español
A Death in San Pedro Sula, Merck Vaccine Moves Forward With Efficacy Trial, While Special Committee Tries to Salvage Thai Study, French African Study Offers Critical Challenge To Generics Obstructionists, Stern Words For Pfizer (added 7/12/04)
Volume 11, Issue 6, June 2004 en español
Top 10 Therapeutic Drug Classes, Expert Panel's Decision To Recommend Against Routine HCV Screening Draws Community Ire, Quirky PK of BI's Tipranavir May Confine Its Use To Limited Rescue Role, Response to U.S. Preventative Services Task Force Recommendations on Screening for HCV Infection (added 6/8/04)
Volume 11, Issue 5, May 2004 en español
R&D Costs, Unplugged, Abbott; Trimeris/Roche Pricing Decisions Rekindle Old R&D Cost Questions; Letters to the Editor; Little Noticed Ban Of Little Used Drug Triggers Little Known Investigation (added 5/13/04)
Volume 11, Issue 4, April 2004
Away They Go: Antiretroviral Patent Expires, Abacavir patent expires in 2009, Vicissitudes of Medicine and Marketing Take Toll on Me-Too Line Up, To The Nines: The Parade of Me-Toos, Sustained Virologic Responses in ACTG A5071, APRICOT and ANRS HC02 (RIBAVIC)
Volume 11, Issue 3, March 2004 en español (nueva traducción 5/17/04)
The Year of Fuzeon, Bungled T-20 Launch Claims Its First Casualties, As Losses Spread, One Shot Immune Based Therapy Would Be Patient Dream-And Pharma's Dread
Volume 11, Issue 2, Febuary 2004 en español
Against the Odds, Immune-Based Therapies for HIV Slog Along, Proliferation of Polymerase Inhibitors and Others Tales from the HCV Crypt
Volume 11, Issue 1, January 2004 en español
The 0.8% Solution, To Date, Global Fund Offers Hype and Hope—But Little Else—To Majority Of Those In Need, For Thousands of PWHIVs, Scale Up=Death, World AIDS Day in Bolivia, Activist Meeting With FDA Drugs Division Sets Broad Agenda for Change
Volume 10, Issue 10, December 2003 en español
Remembering Carlton, Pointers and Prerogatives From and For The Unrepentant Problem Patient, TAG 2003: The Year At A Glance,Expediency, Cost-Cutting Trump Science In Peg-Intron Clinical Development Plan (added 12/18/03)
Volume 10, Issue 9, November 2003 en español
Lexiva Launch: Glaxo Makes Aggressive Push Into Protease Market with New and Improved Amprenavir; Fall Harvest: Bumper Crop of New Drug Approvals in 2003; Scrambling the Code: What A Difference A Nucleotide Makes—Plus IL-15’s Role is STI Outcomes
TAG Update Spring 2003
Interview with Rob Camp, Antiviral Project Director; TAG 2002 Research in Action Awards
Volume 10, Issue 8, October 2003 en español
Global Market Share for HIV Drugs, VaxGen's Claims of Vaccine Efficacy Evanesce In Autumn's Last Light, Congressional Juggling of Medicare Drug Coverage Leaves Many In the Lurch, Sign-on Letter to President re: Domestic AIDS Policies
Volume 10, Issue 7, September 2003 en español
Continental Divide, Rx Américas: Antiretroviral Therapy in Latin America: North of the Southern Cone, A Good Plan Is Hard to Find, ACTing UP for Treatment Access in Latin America, Tragical Realism: Treatment Coverage for Selected Countries, Second Shoe: Doha Dance Has Health Ministries Scheming To Provide Care—Without Pissing Off Uncle Sam
Volume 10, Issue 6, July 2003 en español
Separated at Birth, Latest Licensure Breaks Records for Ho-Hum Reception, Take No Prisoners Tack on TAG Pipeline Report Snubs Host of Drab Wannabes, Seven Agents to Keep Your Eyes On
Volume 10, Issue 5, June 2003 en español
Pill Power, Activist Coalition's Cries Threaten To Scuttle BMS' Race To Full Approval For Wily Reyataz, Debating the Relevance of Super SIVs—Plus Dendritic Cells Make Their Big Screen Debut
Volume 10, Issue 4, May 2003 en español
Pharma in the Cross Hairs; Acute Rx Paradigm Dealt Heavy Blow, While Neutralizing Antibodies Stage A Comeback; Can A Conference (And An Activist) Outlive Its Utility? A Moment Of Unabashed Navel Gazing; TAG at Ten: the year 2002
Volume 10, Issue 3, April 2003 en español
Rapacious Returns, SIre of Twin Failures Hivid and Invirase, Roche Tempts Fate with High Profile T-20 Launch, As MSF, Oxfam Redefined the Possible, Y2K Activist Trek to Durban Marks A Watershed, TAG at Ten: the year 2001
Volume 10, Issue 2, March 2003 en español
Magic with Numbers, Tissue T-Cell Analysis Represents Renewed Challenge to 'Tap and Drain' Orthodoxy, Yokohama, Vancouver, Twin Pacific Ports, Serve As Polar Opposites For Scientific Advances, AIDSVAX Fails to Protect: VaxGen's Claims of Efficacy in Black and Asian Participants are Misleading and Premature, TAG at Ten: the Year 2000
Volume 10, Issue 1, January February 2003 en español
Dubbya's Damascus, Critical Issues from TAG's Forthcoming HCV/HIV Co-infection Report and Analysis, The Boston AIDS Conference That Never Was-And Other Grim Tales, TAG at Year Ten: The Year 1999 (added 2/26/2003)
Volume 9, Issue 9, December 2002 en español
Right Wing Sting, Enemies At the Gate: Storming Montréal's Palais de Congrès, TAG at Ten: The Year 1998, Jabberwocky: Feel Good, 'Why Can't We Just All Be Friends?' Executive Reunion Ends In Promises Aplenty
2002 Research In Action Awards
Program from the awards includes TAG at 10 Years timeline, and tributes to award winners.
Volume 9, Issue 8, November 2002 en español
SSITT Snapshot, Altered States: the Imperiled Future of STI Research, TAG at Ten: The Year 1997, Marking Time: Radioactive reindeer
Volume 9, Issue 7, October 2002 en español
Bodies of Evidence, Double Jeopardy:Series of Superinfection Reports Leave Researchers Debating Not 'If' But 'How'—And What It All Means, Re-infection Data Summarized, The Way Forward: Philly ACT UPer and Health Gap Founder Tackles the Challenges of An Aging Activist Movement
Volume 9, Issue 6, September 2002 en español
International Insecurity, Turn the Beat Around, TAG at 10: the year 1996, Putting It Together
Volume 9, Issue 5, July 2002 en español
Swindling Sam, Consensus Statement in Opposition to Licensure of Remune As Monotherapy for HIV Infection in Thailand, HIV Spread Threatens Decade's Tuberculosis Treatment/Prevention Success, Overwhelming Array of Variables Confounds Interpretation of Co-Infection Studies
TAG Update Spring 2002
Interview with TAG's first Basic Science Project Director, Volunteer Profile, 2001 Research in Action Award Recipients, Organizational and Programmatic Goals.
Volume 9, Issue 4, May 2002 en español
Scrapping Volunteer Model, Studies of PI Resistant Virus, TAG at 10: the year 1995, WHO Antiretroviral Treatment Guidelines
Volume 9, Issue 3, April 2002 en español
Peter Staley on TAG's First Days, Tracking HIV Immunity: the View from Paris, TAG at 10: the Year 1994
Volume 9, Issue 2, March 2002 | en español
Phantom Voices, Activism = Hope, Once We Were Warriors, TAG at 10: The Year 1993
Volume 9, Issue 1, January February 2002 | en español
Double issue newsletter with articles: Annals of Crisis, TAG at 10: The Year 1992, Revenge of the CTLs, A Tale of Two Trials: Vaccine Researcher Questions the Need for Two Massive ALVAC Studies, The Importance of Letting T-Cells Take a Rest, Newly International North American Activist Alliance Gathers in Vancouver. (added 2/20/2002)

Archived issues from 2001 | 2000 | 1999 | 1998 | 1997 | 1996
Always watch for outdated information. These articles first appeared in 1996–1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

TAGLine is published monthly by the Treatment Action Group (TAG)

a 501(c)(3) non-profit treatment advocacy organization in New York City.

TAG home